4.4 Article

Boronic Acids and Beyond: ROS-Responsive Prodrugs as Tools for a Safer and More Effective Cancer Chemotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Reactive oxygen species-responsive polymer drug delivery systems

Jiaxue Liu et al.

Summary: Applying reactive polymer materials sensitive to biological stimuli has attracted extensive research interest. The application of reactive oxygen species (ROS)-responsive polymers as drug-delivery systems in organisms has received much attention due to the special physiological effects of ROS on tumors or inflammation. The research progress of ROS-responsive polymers and their application in recent years were summarized and analyzed in this paper. From the perspective of nanoparticle drug delivery systems, multi-responsive delivery systems, and ROS-responsive hydrogels, the future development trends in this field were discussed.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2023)

Review Biochemistry & Molecular Biology

Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope

Mothana K. Al-Omari et al.

Summary: Boronic acids/esters have gained significant attention in medicinal and pharmaceutical research due to their unique structure, low toxicity, and ability to inhibit enzymes, capture cancer cells, and mimic certain types of antibodies. This review focuses on the potential of boronic acid/ester derivatives as pharmaceutical agents for treating multiple myeloma, prostate cancer, breast cancer, lung cancer, cervical cancer, and colon cancer. Although some newly developed boron-containing compounds have shown promising activities, further investigation is necessary before definitive conclusions can be drawn.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Photoactivation of Boronic Acid Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example

Moyi Liu et al.

Summary: Boronic acid (or ester) is commonly used in the development of anticancer prodrugs, but their application is hindered by low activation efficiency. In this study, a photoactivation approach was developed to convert the boronic acid-caged iridium complex into a bioactive form under hypoxic tumor microenvironments. The mechanism involves the photo-oxidation of phenyl boronate anion to generate a highly reactive phenyl radical, which can capture O2 even at low concentrations. This photoactivation approach shows potent antitumor activities in various experimental models. It can also be extended to activate prodrugs of other anticancer compounds.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Instruments & Instrumentation

Boronates as hydrogen peroxide-reactive warheads in the design of detection probes, prodrugs, and nanomedicines used in tumors and other diseases

Jyun-Wei Chen et al.

Summary: This article highlights the significance of boronate-based probes in modulating and detecting H2O2 levels, and discusses their applications in cell imaging, prodrug nanoplatforms, nanomedicines, and electrochemical biosensors for disease diagnosis and treatment.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Review Biochemistry & Molecular Biology

Recent Advances in Hydrogen Peroxide Responsive Organoborons for Biological and Biomedical Applications

Eron Saxon et al.

Summary: This review discusses the importance of hydrogen peroxide in various disease conditions and the reactivity of organoborons with H2O2, providing a method for developing chemoselective molecules for biological and medical applications. Additionally, it highlights the design and application of boron-derived molecules for H2O2 detection, as well as the utility of boron moieties for masking reactive compounds.

CHEMBIOCHEM (2022)

Article Polymer Science

Boronic Acid Esters and Anhydrates as Dynamic Cross-Links in Vitrimers

Mateusz Gosecki et al.

Summary: This review discusses the development of vitrimers and the synthesis of covalent adaptable networks based on boronic acid linkages. Boronic acid linkages have gained attention due to their fast exchange kinetics and wide application in various polymer systems. The field faces some challenges, but also has promising future prospects.

POLYMERS (2022)

Article Polymer Science

Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines

Arianna Rinaldi et al.

Summary: Reactive oxygen species (ROS)-sensitive drug delivery systems (DDS) that specifically respond to altered levels of ROS have emerged as an effective way to enhance the pharmaceutical efficacy of nanomedicines while reducing side effects. The use of ROS-responsive thioketal (TK) functional group in smart DDS has grown exponentially in recent years. TK-based biomaterials have been used as linkers, prodrugs, core components, gate controllers, and conformation changers in smart nanomedicines to overcome the limitations of conventional DDS and improve disease targeting.

POLYMERS (2022)

Article Chemistry, Inorganic & Nuclear

4-Ferrocenylaniline-based ROS-responsive prodrugs with anticancer activity

Hong-Gui Xu et al.

Summary: Ferrocene derivatives have potential anticancer activity, but their chemical stability remains a challenge. In this study, new 4-ferrocenylaniline-based prodrugs were developed, which showed improved stability and activity compared to previous ferrocene prodrugs. They exhibited anticancer activity through ROS generation.

JOURNAL OF ORGANOMETALLIC CHEMISTRY (2022)

Article Chemistry, Medicinal

The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry

Katia Messner et al.

Summary: This review discusses the history of boron's early use in drugs and the use of boron functional groups in medicinal chemistry. It highlights critical developments from these functional groups and showcases the application of boron in prodrugs, softdrugs, and nanocarriers.

PHARMACEUTICALS (2022)

Article Biochemistry & Molecular Biology

Allyl phenyl selenides as H2O2 acceptors to develop ROS-responsive theranostic prodrugs

Xue-Yan Yang et al.

Summary: In this study, a series of novel H2O2-activated theranostic prodrugs were developed with improved stability and selectivity. By selectively activating fluorescence signals, these prodrugs can be used for real-time monitoring of drug release and H2O2 generation, which holds potential applications in tumor therapy.

BIOORGANIC CHEMISTRY (2022)

Review Materials Science, Biomaterials

Thioether-based ROS responsive polymers for biomedical applications

Miryam Criado-Gonzalez et al.

Summary: Reactive oxygen species (ROS) play important roles in biological functions and can be used to develop stimuli-responsive biomaterials. Thioether-based ROS-responsive polymers can self-assemble into nanoparticles or hydrogels, making them ideal drug carriers for local therapies. This review summarizes the synthesis, self-assembly properties, and applications of thioether-based ROS-responsive nanoparticles and hydrogels, particularly in cancer therapies.

JOURNAL OF MATERIALS CHEMISTRY B (2022)

Article Chemistry, Multidisciplinary

Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates**

Joao P. M. Antonio et al.

Summary: ADCs are a new class of therapeutics combining cytotoxic drugs and antibodies to selectively deliver drugs to cancer cells. The synthesis of a ROS-responsive ADC in this study demonstrated the effectiveness of DABs and their potential for constructing different ROS-responsive linkers. DFT calculations showed a favorable energetic profile, enabling the site-selective functionalization of antibody domains and construction of homogeneous ADCs.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Multidisciplinary

ROS activated prodrug for ALDH overexpressed cancer stem cells

Miae Won et al.

Summary: ALDH, a cancer stem cell biomarker associated with drug resistance, can be targeted using a prodrug called DE-CPT, which efficiently decreases the population of CSCs and kills cancer cells.

CHEMICAL COMMUNICATIONS (2021)

Article Chemistry, Medicinal

Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases

Pengfei Wang et al.

Summary: The study focuses on the role of reactive oxygen species in various diseases and the development of drugs for the targeted treatment and precise diagnosis of ROS-related diseases, also discussed are the activation mechanisms of ROS-responsive prodrugs.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

An Endoplasmic Reticulum Specific Pro-amplifier of Reactive Oxygen Species in Cancer Cells

Hong-Gui Xu et al.

Summary: Novel ER-targeted prodrugs have been developed with activation only in cancer cells, demonstrating anticancer efficacy and cancer cell specificity. These prodrugs induce ER stress, attenuate mitochondrial membrane potential, and generate mitochondrial ROS leading to cell death via necrosis. Activation of the new prodrugs has also been demonstrated in the Nemeth-Kellner lymphoma murine model.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Review Engineering, Chemical

Evolution of Nitrogen-Based Alkylating Anticancer Agents

Fredrik Lehmann et al.

Summary: Despite significant advancements in anticancer drug development, there is a critical need for novel agents with unique but effective mechanisms to combat highly aggressive and drug-resistant tumors. Alkylating agents, particularly nitrogen-based ones, are commonly used for hematological and solid malignancies, exerting their antineoplastic effects throughout the cell cycle. Certain alkylating agents have been designed to enhance penetration into cells and increase their activity against tumors.

PROCESSES (2021)

Review Chemistry, Multidisciplinary

Reactive Oxygen Species Responsive Polymers for Drug Delivery Systems

Fengxiang Gao et al.

Summary: Reactive oxygen species (ROS) play a vital role in regulating physiological functions, but elevated ROS levels can lead to diseases. ROS-responsive polymer carriers offer advantages such as targeted drug delivery, reduced toxicity on normal cells, and controlled drug release compared to traditional chemotherapy agents. These formulations have great potential in biomedicine and are the focus of research for future applications.

FRONTIERS IN CHEMISTRY (2021)

Review Oncology

5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent

Soudeh Ghafouri-Fard et al.

Summary: Non-coding RNAs play a central role in determining the response of patients to 5-FU by modulating cancer-related pathways and cell behavior; Modulating the expression levels of microRNAs or long non-coding RNAs may sensitize tumor cells to 5-FU treatment; There is increasing interest in targeting these transcripts in various cancers treated with 5-FU.

FRONTIERS IN ONCOLOGY (2021)

Article Pharmacology & Pharmacy

ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer

Jiachi Ma et al.

Summary: An innovative UA dimeric prodrug delivery system was developed, which can release UA in response to ROS to inhibit gastric cancer growth and enhance antitumor effect; this system features high drug loading, stable nanoparticles, and increased tumor targeting, showing potential for clinical applications of UA.

DRUG DELIVERY (2021)

Article Biochemistry & Molecular Biology

Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib

Bjoern Bielec et al.

MOLECULES (2020)

Article Biochemistry & Molecular Biology

Histone Deacetylase 2 (HDAC2) Inhibitors Containing Boron

Poya Kavianpour et al.

CHEMBIOCHEM (2020)

Review Chemistry, Organic

Arylboronic Acids and their Myriad of Applications Beyond Organic Synthesis

Noemi de Jesus Hiller et al.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2020)

Review Chemistry, Medicinal

Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment

Hichem Maslah et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells

Viktor Reshetnikov et al.

MOLECULES (2020)

Review Biochemistry & Molecular Biology

Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications

Mariana Pereira Silva et al.

MOLECULES (2020)

Review Biochemistry & Molecular Biology

Role of Glutathione in Cancer: From Mechanisms to Therapies

Luke Kennedy et al.

BIOMOLECULES (2020)

Review Chemistry, Organic

Thiazolidinones: Synthesis, Reactivity, and Their Biological Applications

Sonam Nirwan et al.

JOURNAL OF HETEROCYCLIC CHEMISTRY (2019)

Article Chemistry, Multidisciplinary

ROS-responsive thioether-based nanocarriers for efficient pro-oxidant cancer therapy

Yoon-Seok Kim et al.

JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2019)

Review Oncology

Prodrugs for targeted cancer therapy

Carla Souza et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2019)

Review Biochemistry & Molecular Biology

Recent Advances on Reactive Oxygen Species-Responsive Delivery and Diagnosis System

Huan Ye et al.

BIOMACROMOLECULES (2019)

Article Biochemistry & Molecular Biology

Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer

Charles Skarbek et al.

BIOORGANIC CHEMISTRY (2019)

Review Polymer Science

Oxidation-Responsive Materials: Biological Rationale, State of the Art, Multiple Responsiveness, and Open Issues

Farah El-Mohtadi et al.

MACROMOLECULAR RAPID COMMUNICATIONS (2019)

Article Chemistry, Medicinal

Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach

Yong Ai et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Review Chemistry, Multidisciplinary

Boronic acids as building blocks for the construction of therapeutically useful bioconjugates

Joao P. M. Antonio et al.

CHEMICAL SOCIETY REVIEWS (2019)

Review Biochemistry & Molecular Biology

Prodrug strategies for targeted therapy triggered by reactive oxygen species

Jorge Peiro Cadahia et al.

MEDCHEMCOMM (2019)

Article Chemistry, Organic

Organic CO Prodrugs Activated by Endogenous ROS

Zhixiang Pan et al.

ORGANIC LETTERS (2018)

Article Chemistry, Inorganic & Nuclear

A cancer specific oxaliplatin-releasing Pt(IV)-prodrug

Viktor Reshetnikov et al.

DALTON TRANSACTIONS (2018)

Article Pharmacology & Pharmacy

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy

Jincheng Yang et al.

DRUG DELIVERY (2018)

Review Chemistry, Medicinal

Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives

Rajesh K. Singh et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis

Nikolaj S. Andersen et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution

Steffen Daum et al.

JOURNAL OF INORGANIC BIOCHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Thiazoles and Thiazolidinones as COX/LOX Inhibitors

Konstantinos Liaras et al.

MOLECULES (2018)

Review Biotechnology & Applied Microbiology

The expanding role of prodrugs in contemporary drug design and development

Jarkko Rautio et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Review Pharmacology & Pharmacy

Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment

Hitisha K. Patel et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Chemistry, Medicinal

Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors

Shilong Zheng et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Chemistry, Multidisciplinary

ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria

Viktor Reshetnikov et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Review Chemistry, Medicinal

Prodrug strategy for cancer cell-specific targeting: A recent overview

Xian Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Multidisciplinary

Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs

Steffen Daum et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)

Article Chemistry, Multidisciplinary

Cancer-Specific, Intracellular, Reductive Activation of Anticancer PtIV Prodrugs

Viktor Reshetnikov et al.

CHEMISTRY-A EUROPEAN JOURNAL (2017)

Article Chemistry, Multidisciplinary

A Red Light Activatable Multifunctional Prodrug for Image-Guided Photodynamic Therapy and Cascaded Chemotherapy

Li-Han Liu et al.

ADVANCED FUNCTIONAL MATERIALS (2016)

Article Chemistry, Medicinal

10-Boronic acid substituted camptothecin as prodrug of SN-38

Lei Wang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD)

Jiawang Liu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Medicine, Research & Experimental

HDACs and HDAC Inhibitors in Cancer Development and Therapy

Yixuan Li et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Review Biotechnology & Applied Microbiology

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases

Elizabeth E. Hull et al.

BIOMED RESEARCH INTERNATIONAL (2016)

Review Biotechnology & Applied Microbiology

ROS-responsive drug delivery systems

Jing Liang et al.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2016)

Review Biochemistry & Molecular Biology

Selenium compounds as therapeutic agents in cancer

Aristi P. Fernandes et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)

Article Chemistry, Medicinal

Activity of aminoferrocene-based prodrugs against prostate cancer

Margot Schikora et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Oncology

Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer

Changde Zhang et al.

BREAST CANCER RESEARCH AND TREATMENT (2015)

Article Chemistry, Multidisciplinary

Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs

Christian Perez et al.

CHEMICAL COMMUNICATIONS (2015)

Article Chemistry, Medicinal

Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release

Kevin B. Daniel et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Multidisciplinary Sciences

Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death

Joungyoun Noh et al.

NATURE COMMUNICATIONS (2015)

Review Chemistry, Multidisciplinary

Selection of boron reagents for Suzuki-Miyaura coupling

Alastair J. J. Lennox et al.

CHEMICAL SOCIETY REVIEWS (2014)

Article Chemistry, Multidisciplinary

Aromatic Nitrogen Mustard-Based Prodrugs: Activity, Selectivity, and the Mechanism of DNA Cross-Linking

Wenbing Chen et al.

CHEMISTRY-A EUROPEAN JOURNAL (2014)

Article Chemistry, Organic

The Leaving Group Strongly Affects H2O2-Induced DNA Cross-Linking by Arylboronates

Sheng Cao et al.

JOURNAL OF ORGANIC CHEMISTRY (2014)

Article Chemistry, Medicinal

Discovery of alkenylboronic acids as neuroprotective agents affecting multiple biological targets involved in Alzheimer's disease

Karim Jimenez-Aligaga et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Multidisciplinary

Substituent Effects on Oxidation-Induced Formation of Quinone Methides from Arylboronic Ester Precursors

Sheng Cao et al.

CHEMISTRY-A EUROPEAN JOURNAL (2013)

Article Chemistry, Medicinal

Post SELECT: selenium on trial

Arun K. Sharma et al.

FUTURE MEDICINAL CHEMISTRY (2013)

Article Chemistry, Medicinal

Aminoferrocene-Based Prodrugs and Their Effects on Human Normal and Cancer Cells as Well as Bacterial Cells

Paul Marzenell et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Chemistry, Multidisciplinary

ROS-Inducible DNA Cross-Linking Agent as a New Anticancer Prodrug Building Block

Sheng Cao et al.

CHEMISTRY-A EUROPEAN JOURNAL (2012)

Article Chemistry, Medicinal

Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species

Helen Hagen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Chemistry, Medicinal

Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer

Quan Jiang et al.

ACS MEDICINAL CHEMISTRY LETTERS (2012)

Article Pharmacology & Pharmacy

ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage

Xiaohua Peng et al.

THERAPEUTIC DELIVERY (2012)

Article Biochemistry & Molecular Biology

Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide

Kevin B. Daniel et al.

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)

Article Chemistry, Multidisciplinary

Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs

Yunyan Kuang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)

Article Chemistry, Multidisciplinary

Quinone Methides Tethered to Naphthalene Diimides as Selective G-Quadruplex Alkylating Agents

Marco Di Antonio et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)

Review Biotechnology & Applied Microbiology

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Dunyaporn Trachootham et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Biotechnology & Applied Microbiology

Epigenetic interplay between histone modifications and DNA methylation in gene silencing

Thomas Vaissiere et al.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)

Review Biotechnology & Applied Microbiology

Prodrugs: design and clinical applications

Jarkko Rautio et al.

NATURE REVIEWS DRUG DISCOVERY (2008)

Article Pharmacology & Pharmacy

Tumor-targeted induction of oxystress for cancer therapy

J. Fang et al.

JOURNAL OF DRUG TARGETING (2007)

Article Chemistry, Multidisciplinary

A design of fluorescent probes for superoxide based on a nonredox mechanism

H Maeda et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)

Article Chemistry, Multidisciplinary

Fluorescent probes for hydrogen peroxide based on a non-oxidative mechanism

H Maeda et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)